Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle

Circulation Research

Volumn 83, Issue 8, 1998, Pages 841-851

  Sabri, Abdelkarim ^a   Govindarajan, Geetha ^a   Griffin, Tina M ^a   Byron, Kenneth L ^a   Samarel, Allen M ^a   Lucchesi, Pamela A ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Angiotensin II; Ca2+; Protein kinase C; PYK2; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0032547831     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.8.841     Document Type: Article

References (48)

1. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
2. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
3. Paquet JL, Baudouin-Legros M, Brunelle G, Meyer P. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens. 1990;8:565-572.
4. 2+ mobilization and protein kinase C activation. J Biol Chem. 1989;264:526-530.
5. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
6. Gibbons GH, Dzau VJ. Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension. Cardiovasc Drugs Ther. 1990;4:237-242.
7. Pratt RE. Regulation of vascular smooth-muscle cell growth by angiotensin II. Blood Press Suppl. 1996;2:6-9.
8. Rosendorff C. The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol. 1996;28:803-812.
9. de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans P. Proposed update of angiotensin receptor nomenclature. Hypertension. 1995;25:924-927.
10. Timmermans P, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
11. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
12. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Circ Res. 1997;80:607-616.
13. Linseman DA, Benjamin CW, Jones DA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem. 1995;270:12563-12568.
14. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J Biol Chem. 1994;269:10935-10939.
15. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247-250.
16. Polte TR, Naftilan AJ, Hanks SK. Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II. J Cell Biochem. 1994;55:106-119.
17. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk BC. Angiotensin II activates pp60(c-src) in vascular smooth muscle cells. Circ Res. 1995;77:1053-1059.
18. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
19. Tsuda T, Kawahara Y, Ishida Y, Koide M, Shii K, Yokoyama M. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ Res. 1992;71:620-630.
20. Lucchesi PA, Bell JM, Willis LS, Byron KL, Corson MA, Berk BC. Calcium-dependent MAP kinase activation in SHR defines a hypertensive signal transduction phenotype. Circ Res. 1996;78:962-979.
21. 2+/ calmodulin-sensitive tyrosine kinase. J Biol Chem. 1996;271:14169-14175.
22. Liao D-F, Duff JL, Daum G, Pelech SL, Berk BC. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells. Circ Res. 1996;79:1007-1014.
23. Sasaki H, Nagura K, Ishino M, Tobioka H, Kotani K, Sasaki T. Cloning and characterization of cell adhesion kinase β, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem. 1995;270:21206-21219.
24. 2+-induced regulation of ion channel and MAP kinase function. Nature. 1995;376:737-745.
25. Avraham S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE, Avraham H. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem. 1995;270:27742-27751.
26. Yu H, Li X, Marchetto GS, Dy R, Hunter D, Calvo B, Dawson TL, Wilm M, Anderegg RJ, Graves LM, Earp HS. Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-jun N-terminal kinase but not mitogen-activated protein kinase activation. J Biol Chem. 1996;271:29993-29998.
27. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for PYK2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 1996;383:547-550.
28. Astier A, Avraham H, Manie SN, Groopman J, Canty T, Avraham S, Freedman AS. The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas. J Biol Chem. 1997;272:228-232.
29. Berg NN, Ostergaard HL. T cell receptor engagement induces tyrosine phosphorylation of FAK and Pyk2 and their association with Lyk. J Immunol. 1997;159:1753-1757.
30. Cazaubon S, Chaverot N, Romero IA, Girault JA, Adamson P, Strosberg AD, Couraud PO. Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways. J Neurosci. 1997;17:6203-6212.
31. Siciliano JC, Toutant M, Derkinderen P, Sasaki T, Girault JA. Differential regulation of proline-rich tyrosine kinase 2/cell adhesion kinase beta (PYK2/CAKbeta) and pp125 (FAK) by glutamate and depolarization in rat hippocampus. J Biol Chem. 1996;271:28942-28946.
32. Hiregowdara D, Avraham H, Fu Y, London R, Avraham S. Tyrosine phosphorylation of the related adhesion focal tyrosine kinase in megakaryocytes upon stem cell factor and phorbol myristate acetate stimulation and its association with paxillin. J Biol Chem. 1997;272:10804-10810.
33. Zheng C, King Z, Bian C, Guo G, Akbay A, Warner L, Guan J-L. Differential regulation of PYK2 and focal adhesion kinase (FAK). J Biol Chem. 1998;273:2384-2389.
34. Giasson G, Servant MJ, Meloche S. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle. J Biol Chem. 1997;272:26879-26896.
35. Brinson AE, Harding T, Diliberto PA, He Y, Li X, Hunter D, Herman B, Earp HS, Graves LM. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. J Biol Chem. 1998;273:1711-1718.
36. Sabri A, Griffin T, Lucchesi P. Angiotensin II activates the proline-rich-tyrosine kinase 2 (PYK2) in vascular smooth muscle. Circulation Suppl 1997;98:1-46.
37. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol. 1997;17:257-264.
38. Ishida M, Ishida T, Thomas S, Berk B. Activation of extracellular signal-regulated kinases (ERK 1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle. Circ Res. 1998;82:7-12.
39. Hebert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993-999.
40. Touyz RM, Schriffin EL. Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways. Hypertension. 1997;30:1440-1447.
41. Yasutake M, Haworth RS, King A, Avkiran M. Thrombin activates the sarcolemmal Na(+)-H+ exchanger. Evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res. 1996;79:705-715.
42. + current in rabbit vascular myocytes. J Physiol. 1996;495:689-700.
43. Xiong W, Parsons JT. Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase. J Cell Biol. 1997;139:529-539.
44. src. Mol Cell Biol. 1994;14:1680-1688.
45. McGlade J, Cheng A, Pelicci PG, Pawson T. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein tyrosine kinases. Proc Natl Acad Sci U S A. 1992;89:8869-8873.
46. Yamaguchi M, Tanaka T, Waki M, Kitanaka A, Kamano H, Kubota Y, Ohnishi H, Takahara J, Irino S. Antisense src expression inhibits tyrosine phosphorylation of Shc and its association with Grb2 and Sos which leads to MAP kinase activation in U937 human leukemia cells. Leukemia. 1997;11:497-503.
47. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ. Ras-dependent mitogen-activated protein kinase activation by G-protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem. 1997;272:19125-19132.
48. Felsch JS, Cachero TG, Peralta E. G Activation of protein tyrosine kinase PYK2 by the M1 muscarinic acetylcholine receptor. Proc Natl Acad Sci U S A. 1998;95:5051-5056.